VCRE
Vicore Pharma Holding AB
8.80$
+1.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| -1,002.8% | -9,653.9% | -6,096.8% | – | -19,445.8% | -19,541.7% | -7,045.5% | – | |
| 469.7% | 288.2% | -34.4% | – | 8,732.5% | 392.9% | -657.5% | – | |
| 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | 0.9% | – | – | – | 0.0% | – | |
| 16,032.3% | -47,080.6% | -20,431.0% | – | 26,656.6% | -34,269.8% | 2,224.8% | – | |
| -1,002.8% | -9,653.9% | -6,096.8% | – | -19,445.8% | -19,541.7% | -7,045.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.